Literature DB >> 20338923

Cyclin D1 regulates hepatic estrogen and androgen metabolism.

Lisa K Mullany1, Eric A Hanse, Andrea Romano, Charles H Blomquist, J Ian Mason, Bert Delvoux, Chelsea Anttila, Jeffrey H Albrecht.   

Abstract

Cyclin D1 is a cell cycle control protein that plays an important role in regenerating liver and many types of cancer. Previous reports have shown that cyclin D1 can directly enhance estrogen receptor activity and inhibit androgen receptor activity in a ligand-independent manner and thus may play an important role in hormone-responsive malignancies. In this study, we examine a distinct mechanism by which cyclin D1 regulates sex steroid signaling, via altered metabolism of these hormones at the tissue and cellular level. In male mouse liver, ectopic expression of cyclin D1 regulated genes involved in the synthesis and degradation of sex steroid hormones in a pattern that would predict increased estrogen and decreased androgen levels. Indeed, hepatic expression of cyclin D1 led to increased serum estradiol levels, increased estrogen-responsive gene expression, and decreased androgen-responsive gene expression. Cyclin D1 also regulated the activity of several key enzymatic reactions in the liver, including increased oxidation of testosterone to androstenedione and decreased conversion of estradiol to estrone. Similar findings were seen in the setting of physiological cyclin D1 expression in regenerating liver. Knockdown of cyclin D1 in HuH7 cells produced reciprocal changes in steroid metabolism genes compared with cyclin D1 overexpression in mouse liver. In conclusion, these studies establish a novel link between the cell cycle machinery and sex steroid metabolism and provide a distinct mechanism by which cyclin D1 may regulate hormone signaling. Furthermore, these results suggest that increased cyclin D1 expression, which occurs in liver regeneration and liver diseases, may contribute to the feminization seen in these settings.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20338923      PMCID: PMC2907223          DOI: 10.1152/ajpgi.00471.2009

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  42 in total

1.  Cellular and molecular targets of estrogen in normal human breast tissue.

Authors:  Pankaj Seth; Dale Porter; Jaana Lahti-Domenici; Yan Geng; Andrea Richardson; Kornelia Polyak
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

2.  Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis.

Authors:  Mark W Landis; Basil S Pawlyk; Tiansen Li; Piotr Sicinski; Philip W Hinds
Journal:  Cancer Cell       Date:  2006-01       Impact factor: 31.743

3.  The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro.

Authors:  A Francavilla; L Polimeno; A DiLeo; M Barone; P Ove; M Coetzee; P Eagon; L Makowka; G Ambrosino; V Mazzaferro
Journal:  Hepatology       Date:  1989-04       Impact factor: 17.425

4.  Transient expression of cyclin D1 is sufficient to promote hepatocyte replication and liver growth in vivo.

Authors:  C J Nelsen; D G Rickheim; N A Timchenko; M W Stanley; J H Albrecht
Journal:  Cancer Res       Date:  2001-12-01       Impact factor: 12.701

5.  Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection.

Authors:  Aileen Marshall; Simon Rushbrook; Susan E Davies; Lesley S Morris; Ian S Scott; Sarah L Vowler; Nicholas Coleman; Graeme Alexander
Journal:  Gastroenterology       Date:  2005-01       Impact factor: 22.682

Review 6.  Modelling the molecular circuitry of cancer.

Authors:  William C Hahn; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

Review 7.  Minireview: Cyclin D1: normal and abnormal functions.

Authors:  Maofu Fu; Chenguang Wang; Zhiping Li; Toshiyuki Sakamaki; Richard G Pestell
Journal:  Endocrinology       Date:  2004-08-26       Impact factor: 4.736

8.  Androgen metabolism and biotransformation in nontumoral and malignant human liver tissues and cells.

Authors:  Orazia M Granata; Letizia Cocciadifero; Ildegarda Campisi; Vitale Miceli; Giuseppe Montalto; Lucia M Polito; Biagio Agostara; Giuseppe Carruba
Journal:  J Steroid Biochem Mol Biol       Date:  2009-02-07       Impact factor: 4.292

9.  Distinct proliferative and transcriptional effects of the D-type cyclins in vivo.

Authors:  Lisa K Mullany; Peter White; Eric A Hanse; Christopher J Nelsen; Melissa M Goggin; Joseph E Mullany; Chelsea K Anttila; Linda E Greenbaum; Klaus H Kaestner; Jeffrey H Albrecht
Journal:  Cell Cycle       Date:  2008-05-12       Impact factor: 4.534

10.  17beta-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer.

Authors:  C Gunnarsson; E Hellqvist; O Stål
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

View more
  10 in total

1.  Cyclin D1 in the Liver: Role of Noncanonical Signaling in Liver Steatosis and Hormone Regulation.

Authors:  Kelley G Núñez; Janet Gonzalez-Rosario; Paul T Thevenot; Ari J Cohen
Journal:  Ochsner J       Date:  2017

2.  Expression of hepatic 3β-hydroxysteroid dehydrogenase and sulfotransferase 2A1 in entire and castrated male pigs.

Authors:  Martin Krøyer Rasmussen; Carl Brunius; Bo Ekstrand; Galia Zamaratskaia
Journal:  Mol Biol Rep       Date:  2012-04-29       Impact factor: 2.316

3.  Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α.

Authors:  Eric A Hanse; Douglas G Mashek; Jennifer R Becker; Ashley D Solmonson; Lisa K Mullany; Mara T Mashek; Howard C Towle; Anhtung T Chau; Jeffrey H Albrecht
Journal:  Cell Cycle       Date:  2012-07-15       Impact factor: 4.534

4.  A negative reciprocal regulatory axis between cyclin D1 and HNF4α modulates cell cycle progression and metabolism in the liver.

Authors:  Heng Wu; Tzachi Reizel; Yue J Wang; Jessica L Lapiro; Betsy T Kren; Jonathan Schug; Shilpa Rao; Ashleigh Morgan; Adam Herman; Laurie L Shekels; Matthew S Rassette; Andrew N Lane; Teresa Cassel; Teresa W M Fan; Juan C Manivel; Sumedha Gunewardena; Udayan Apte; Piotr Sicinski; Klaus H Kaestner; Jeffrey H Albrecht
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-06       Impact factor: 12.779

Review 5.  Regulation of 3β-hydroxysteroid dehydrogenase/Δ⁵-Δ⁴ isomerase: a review.

Authors:  Martin Krøyer Rasmussen; Bo Ekstrand; Galia Zamaratskaia
Journal:  Int J Mol Sci       Date:  2013-09-02       Impact factor: 5.923

6.  Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis.

Authors:  Janaki K Iyer; Mamta Kalra; Anil Kaul; Mark E Payton; Rashmi Kaul
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

7.  SAK-HV Triggered a Short-period Lipid-lowering Biotherapy Based on the Energy Model of Liver Proliferation via a Novel Pathway.

Authors:  Chao Zhang; Zhiguang Huang; Haoran Jing; Wenliang Fu; Min Yuan; Wenrong Xia; Ling Cai; Xiangdong Gan; Yao Chen; Minji Zou; Minhui Long; Jiaxi Wang; Min Wang; Donggang Xu
Journal:  Theranostics       Date:  2017-04-10       Impact factor: 11.556

8.  Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation.

Authors:  Sushama Kamarajugadda; Jennifer R Becker; Eric A Hanse; Douglas G Mashek; Mara T Mashek; Anna M Hendrickson; Lisa K Mullany; Jeffrey H Albrecht
Journal:  Oncotarget       Date:  2016-07-26

9.  Evidence for a Novel Regulatory Interaction Involving Cyclin D1, Lipid Droplets, Lipolysis, and Cell Cycle Progression in Hepatocytes.

Authors:  Heng Wu; Jonathan M Ploeger; Sushama Kamarajugadda; Douglas G Mashek; Mara T Mashek; Juan C Manivel; Laurie L Shekels; Jessica L Lapiro; Jeffrey H Albrecht
Journal:  Hepatol Commun       Date:  2019-01-30

10.  Cyclin D1 goes metabolic: dual functions of cyclin D1 in regulating lipogenesis.

Authors:  Karen E Knudsen
Journal:  Cell Cycle       Date:  2012-09-05       Impact factor: 4.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.